CARIS CHROMOSEQ Trademark

Trademark Overview

On Friday, October 10, 2025, a trademark application was filed for CARIS CHROMOSEQ with the United States Patent and Trademark Office. The USPTO has given the CARIS CHROMOSEQ trademark a serial number of 99437005. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, October 10, 2025. This trademark is owned by Caris MPI, Inc.. The CARIS CHROMOSEQ trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies
caris chromoseq

General Information

Serial Number99437005
Word MarkCARIS CHROMOSEQ
Filing DateFriday, October 10, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, October 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of three concentric arches with the words CARIS CHROMOSEQ below the arches. The "A" in "CARIS" is in a stylized format.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical testing for diagnostic, prognostic, or treatment purposes; medical testing, namely, providing whole genome and whole transcriptome sequencing assays for biomarker detection in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies
Goods and ServicesMedical and scientific research in the field of oncology; providing medical and scientific research information in the field of oncology; medical and scientific research, namely, whole genome and whole transcriptome sequencing assays for biomarker detection and analysis in patients with leukemia, lymphoma, myeloma, or other hematologic malignancies

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 10, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, October 10, 2025
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCaris MPI, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIrving, TX 75039

Trademark Events

Event DateEvent Description
Friday, October 10, 2025NEW APPLICATION ENTERED
Friday, October 10, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

chromoseq caris medical whole scientific research myeloma lymphoma leukemia patients hematologic oncology